Humacyte Price Cash Flow Ratio from 2010 to 2024

HUMAW Stock  USD 1.47  0.03  2.00%   
Humacyte Price Cash Flow Ratio yearly trend continues to be fairly stable with very little volatility. Price Cash Flow Ratio will likely drop to -4.21 in 2024. During the period from 2010 to 2024, Humacyte Price Cash Flow Ratio regression line of quarterly data had r-squared of  0.42 and coefficient of variation of (18.41). View All Fundamentals
 
Price Cash Flow Ratio  
First Reported
2010-12-31
Previous Quarter
(4.01)
Current Value
(4.21)
Quarterly Volatility
0.54278886
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Humacyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Humacyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.7 M, Interest Expense of 1.1 M or Selling General Administrative of 21.1 M, as well as many indicators such as Price To Sales Ratio of 96.95, Dividend Yield of 0.0 or PTB Ratio of 22.77. Humacyte financial statements analysis is a perfect complement when working with Humacyte Valuation or Volatility modules.
  
Check out the analysis of Humacyte Correlation against competitors.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.

Latest Humacyte's Price Cash Flow Ratio Growth Pattern

Below is the plot of the Price Cash Flow Ratio of Humacyte over the last few years. It is Humacyte's Price Cash Flow Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Humacyte's overall financial position and show how it may be relating to other accounts over time.
Price Cash Flow Ratio10 Years Trend
Slightly volatile
   Price Cash Flow Ratio   
       Timeline  

Humacyte Price Cash Flow Ratio Regression Statistics

Arithmetic Mean(2.95)
Coefficient Of Variation(18.41)
Mean Deviation0.41
Median(2.71)
Standard Deviation0.54
Sample Variance0.29
Range1.9316
R-Value(0.65)
Mean Square Error0.18
R-Squared0.42
Significance0.01
Slope(0.08)
Total Sum of Squares4.12

Humacyte Price Cash Flow Ratio History

2024 -4.21
2023 -4.01
2022 -3.06
2021 -3.57
2020 -2.28

About Humacyte Financial Statements

Humacyte investors use historical fundamental indicators, such as Humacyte's Price Cash Flow Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Humacyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Cash Flow Ratio(4.01)(4.21)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Humacyte Stock Analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.